Correlation Between Akero Therapeutics and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Keros Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Keros Therapeutics.
Diversification Opportunities for Akero Therapeutics and Keros Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akero and Keros is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Keros Therapeutics
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.25 times more return on investment than Keros Therapeutics. However, Akero Therapeutics is 1.25 times more volatile than Keros Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 2,971 in Akero Therapeutics on August 27, 2024 and sell it today you would earn a total of 206.00 from holding Akero Therapeutics or generate 6.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Keros Therapeutics
Performance |
| Timeline |
| Akero Therapeutics |
| Keros Therapeutics |
Akero Therapeutics and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Keros Therapeutics
The main advantage of trading using opposite Akero Therapeutics and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |